Age-specific pancreatic cancer risk in Italian CDKN2A families
Digestive and Liver Disease · 2026
DOI: 10.1016/j.dld.2026.09.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2026. Verfasst von Bruna Dalmasso und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Genetics Unit, IRCCS Azienda Ospedaliera Metropolitana - Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: brunasamia.dalmas…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Humanities in the European Research Area, Ministero dell’Istruzione, dell’Università e della Ricerca, Ministero della Salute.
Abstract (Originalsprache)
BACKGROUND: Pancreatic cancer (PC) risk in carriers of germline CDKN2A pathogenic variants (PV) is among the highest, with a standardized incidence ratio (SIR) of 20 and cumulative incidence >20% by age 70 in Dutch cohorts, informing surveillance protocols with promising results in CDKN2A-positive families. Prospective, lifetime, variant-specific estimates are missing in Italy. PATIENTS AND METHODS: We assessed SIR and cumulative incidence of PC in 202 kindreds carrying germline CDKN2A PV, mostly melanoma-selected and followed for up to 25 years. RESULTS: PC occurred in about one-third of families, with median age at diagnosis of 66 years. Compared with regional cancer registry PC incidence rates, SIR was 34.26 [95%CI= 27.12-42.7]. Cumulative incidence was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Genetics Unit, IRCCS Azienda Ospedaliera Metropolitana - Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: brunasamia.dalmasso@aomliguria.it.
- Cancer Genetics Unit, IRCCS Azienda Ospedaliera Metropolitana - Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, Italy.
- Cancer Genetics Unit, IRCCS Azienda Ospedaliera Metropolitana - Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Diagnostic and Interventional Radiology, IRCCS Azienda Ospedaliera Metropolitana - Ospedale Policlinico San Martino, Genova, Italy.
- Medical Oncology Unit, IRCCS Azienda Ospedaliera Metropolitana - Ospedale Policlinico San Martino, Genoa, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genoa, Genoa, Italy.
- Medical Oncology Unit, IRCCS Azienda Ospedaliera Metropolitana - Ospedale Policlinico San Martino, Genoa, Italy.
Förderung
- Humanities in the European Research Area
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Ministero della Salute
- Ministero dell'Istruzione dell'Università e della Ricerca
- Alliance Against Cancer
Zitieren
APA
Dalmasso, B., Allavena, E., Gambino, A., Barbero, F., Vanni, I., Gorgun, C., Cittadini, G., Spagnolo, F., Tanda, E. T., Boutros, A., Bruno, W., Pastorino, L., & Ghiorzo, P. (2026). Age-specific pancreatic cancer risk in Italian CDKN2A families. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.09.004
Vancouver
Dalmasso B, Allavena E, Gambino A, Barbero F, Vanni I, Gorgun C, et al. Age-specific pancreatic cancer risk in Italian CDKN2A families. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.09.004
BibTeX
@article{Dalmasso2026,
author = {Dalmasso, Bruna and Allavena, Eleonora and Gambino, Andrea and Barbero, Francesca and Vanni, Irene and Gorgun, Cansu and Cittadini, Giuseppe and Spagnolo, Francesco and Tanda, Enrica Teresa and Boutros, Andrea and Bruno, William and Pastorino, Lorenza and Ghiorzo, Paola},
title = {Age-specific pancreatic cancer risk in Italian CDKN2A families},
journal = {Digestive and Liver Disease},
year = {2026},
doi = {10.1016/j.dld.2026.09.004}
}
EUVIMED